Synthesis of nitric oxide in postganglionic myenteric neurons during endotoxemia: implications for gastric motor function in rats

FASEB J. 2004 Mar;18(3):531-3. doi: 10.1096/fj.03-0596fje. Epub 2004 Jan 8.

Abstract

We have investigated the mechanisms underlying acute changes in gastric motor function triggered by endotoxemia. In fundal strips from rats pre-treated with endotoxin (40 microg/kg, i.p. 30 min), mechanical activity was analyzed and the source of nitric oxide (NO) was visualized by confocal microscopy of tissue loaded with the fluorescent dye DAF-FM. NOS expression was determined by quantitative RT-PCR and Western blot, and enzyme activity by the citrulline assay. Strips from endotoxin-treated rats were hypo-contractile. This was prevented by pre-incubation with the neurotoxin tetrodotoxin, the gangliar blocker hexamethonium, or non-selective and neuronal-specific NOS inhibitors (L-NOARG and TRIM, respectively). The soluble guanylyl cyclase (sGC) inhibitor ODQ and the inhibitor of small conductance Ca2+-activated K+ channels apamin prevented relaxation induced by endotoxin, nicotine, exogenous NO (DETA-NONOate), and the NO-independent sGC activator BAY 41-2272. NO synthesis was observed in neuronal soma, axons, and nerve endings of the myenteric plexus in the fundus of endotoxin-treated rats and was prevented by L-NAME, tetrodotoxin, and hexamethonium. nNOS and iNOS mRNA and protein contents were unchanged. Our findings demonstrate synthesis of NO in post-ganglionic myenteric neurons during early endotoxemia that mediates gastric hypo-contractility. The effect of NO is mediated via sGC and small conductance Ca2+-activated K+channels.

MeSH terms

  • Animals
  • Apamin / pharmacology
  • Autonomic Fibers, Postganglionic / metabolism*
  • Carbachol / pharmacology
  • Dexamethasone / pharmacology
  • Endotoxemia / metabolism*
  • Endotoxemia / physiopathology
  • Gastric Fundus / physiopathology
  • Gastrointestinal Motility / drug effects
  • Gastrointestinal Motility / physiology*
  • Guanylate Cyclase / antagonists & inhibitors
  • Guanylate Cyclase / physiology
  • Microscopy, Confocal
  • Nerve Tissue Proteins / metabolism
  • Nicotine / pharmacology
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II
  • Nitroarginine / pharmacology
  • Nitroso Compounds / pharmacology
  • Peptide Fragments / pharmacology
  • Potassium Channels, Calcium-Activated / antagonists & inhibitors
  • Potassium Channels, Calcium-Activated / physiology
  • Pyrazoles / pharmacology
  • Pyridines / pharmacology
  • Pyridoxal Phosphate / analogs & derivatives*
  • Pyridoxal Phosphate / pharmacology
  • Rats
  • Suramin / pharmacology
  • Tetrodotoxin / pharmacology
  • Vasoactive Intestinal Peptide / pharmacology

Substances

  • 3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine
  • Nerve Tissue Proteins
  • Nitric Oxide Donors
  • Nitroso Compounds
  • Peptide Fragments
  • Potassium Channels, Calcium-Activated
  • Pyrazoles
  • Pyridines
  • 2,2'-(hydroxynitrosohydrazono)bis-ethanamine
  • pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
  • Nitroarginine
  • Apamin
  • Nitric Oxide
  • Vasoactive Intestinal Peptide
  • Tetrodotoxin
  • Pyridoxal Phosphate
  • Suramin
  • vasoactive intestinal peptide (10-28)
  • Nicotine
  • Dexamethasone
  • Carbachol
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Guanylate Cyclase